D-0594-2024 Class II Ongoing
FDA drug recall D-0594-2024 was initiated by TAILSTORM HEALTH INC on July 3, 2024 and is designated Class II. Reason for recall: Subpotent Drug: reduced efficacy for epinephrine The recall status is ongoing. Affected quantity: 12,525 10 mL vials.
Recall Details
- Product Type
- Drugs
- Report Date
- July 17, 2024
- Initiation Date
- July 3, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,525 10 mL vials
Product Description
Lidocaine HCL Injection, USP 2% 200mg/10mL (20mg/mL) and EPINEPHRINE HCl 1:200,000, 10 ml Single Dose Vial, Rx only, Compounded drug by Medivant Healthcare, 158 S Kyrene Rd, Chandler, AZ 85226, NDC 81483-0038-0, UPC 3 81483 00380 2
Reason for Recall
Subpotent Drug: reduced efficacy for epinephrine
Distribution Pattern
Nationwide in the USA
Code Information
Lot Number: 2311003, Expiration Date: 11/13/2024